nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—schizophrenia	0.717	1	CbGaD
Nadolol—Penbutolol—HTR1B—schizophrenia	0.00247	0.248	CrCbGaD
Nadolol—Penbutolol—HTR1A—schizophrenia	0.00195	0.196	CrCbGaD
Nadolol—Pindolol—HTR1B—schizophrenia	0.00178	0.179	CrCbGaD
Nadolol—Carteolol—CYP2D6—schizophrenia	0.0015	0.151	CrCbGaD
Nadolol—Pindolol—HTR1A—schizophrenia	0.00141	0.141	CrCbGaD
Nadolol—Pindolol—CYP2D6—schizophrenia	0.000844	0.0848	CrCbGaD
Nadolol—ADRB2—Signaling by GPCR—CCKAR—schizophrenia	0.000112	0.000408	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—NPY—schizophrenia	0.000111	0.000407	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2A—schizophrenia	0.000111	0.000406	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADORA2A—schizophrenia	0.000111	0.000405	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADORA2A—schizophrenia	0.00011	0.000403	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—OXT—schizophrenia	0.00011	0.000402	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR1B—schizophrenia	0.00011	0.000402	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FES—schizophrenia	0.00011	0.000401	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TAAR6—schizophrenia	0.00011	0.000401	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PPP3CC—schizophrenia	0.00011	0.000401	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM2—schizophrenia	0.00011	0.000401	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2A—schizophrenia	0.000108	0.000397	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PLA2G4A—schizophrenia	0.000108	0.000396	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADORA2A—schizophrenia	0.000108	0.000396	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1B—schizophrenia	0.000107	0.000393	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—OXT—schizophrenia	0.000107	0.000393	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR1A—schizophrenia	0.000106	0.000387	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FGA—schizophrenia	0.000105	0.000386	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2A—schizophrenia	0.000105	0.000386	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MPC2—schizophrenia	0.000105	0.000385	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—NPS—schizophrenia	0.000104	0.000381	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGEF—schizophrenia	0.000104	0.00038	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1A—schizophrenia	0.000103	0.000378	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—NPY—schizophrenia	0.000103	0.000378	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NPY—schizophrenia	0.000103	0.000376	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOTCH4—schizophrenia	0.000103	0.000376	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ATP2A2—schizophrenia	0.000103	0.000376	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2C—schizophrenia	0.000102	0.000374	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD1—schizophrenia	0.000102	0.000374	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—NPS—schizophrenia	0.000102	0.000373	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGEF—schizophrenia	0.000101	0.000371	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTS—schizophrenia	0.000101	0.000371	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—NPY—schizophrenia	0.000101	0.00037	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2C—schizophrenia	9.98e-05	0.000365	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD1—schizophrenia	9.98e-05	0.000365	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1B—schizophrenia	9.96e-05	0.000365	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—OXT—schizophrenia	9.96e-05	0.000365	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	9.96e-05	0.000365	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—OXT—schizophrenia	9.92e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1B—schizophrenia	9.92e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTS—schizophrenia	9.91e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD3—schizophrenia	9.88e-05	0.000362	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	9.87e-05	0.000362	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—schizophrenia	9.78e-05	0.000358	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLCH2—schizophrenia	9.78e-05	0.000358	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1B—schizophrenia	9.75e-05	0.000357	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—OXT—schizophrenia	9.75e-05	0.000357	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD3—schizophrenia	9.66e-05	0.000354	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1A—schizophrenia	9.59e-05	0.000351	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD4—schizophrenia	9.59e-05	0.000351	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—schizophrenia	9.57e-05	0.000351	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1A—schizophrenia	9.55e-05	0.00035	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM3—schizophrenia	9.53e-05	0.000349	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RGS4—schizophrenia	9.53e-05	0.000349	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RTN4—schizophrenia	9.53e-05	0.000349	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—NPS—schizophrenia	9.45e-05	0.000346	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NPS—schizophrenia	9.4e-05	0.000344	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	9.38e-05	0.000344	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	9.38e-05	0.000344	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR6—schizophrenia	9.35e-05	0.000342	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RTN4—schizophrenia	9.32e-05	0.000341	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RGS4—schizophrenia	9.32e-05	0.000341	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM3—schizophrenia	9.32e-05	0.000341	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2C—schizophrenia	9.26e-05	0.000339	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD1—schizophrenia	9.26e-05	0.000339	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—NPS—schizophrenia	9.24e-05	0.000338	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2C—schizophrenia	9.22e-05	0.000338	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD1—schizophrenia	9.22e-05	0.000338	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NDST3—schizophrenia	9.19e-05	0.000337	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CNR1—schizophrenia	9.16e-05	0.000335	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR6—schizophrenia	9.15e-05	0.000335	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	9.09e-05	0.000333	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	9.06e-05	0.000332	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	9.06e-05	0.000332	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAG—schizophrenia	9.03e-05	0.000331	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD3—schizophrenia	8.97e-05	0.000329	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NTRK2—schizophrenia	8.97e-05	0.000328	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	8.96e-05	0.000328	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR7—schizophrenia	8.93e-05	0.000327	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD2—schizophrenia	8.93e-05	0.000327	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD3—schizophrenia	8.93e-05	0.000327	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAG—schizophrenia	8.83e-05	0.000324	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	8.78e-05	0.000321	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	8.74e-05	0.00032	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	8.74e-05	0.00032	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ACSL6—schizophrenia	8.71e-05	0.000319	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC27A5—schizophrenia	8.71e-05	0.000319	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD4—schizophrenia	8.71e-05	0.000319	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD4—schizophrenia	8.67e-05	0.000317	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	8.52e-05	0.000312	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—schizophrenia	8.41e-05	0.000308	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CNR1—schizophrenia	8.32e-05	0.000305	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DAO—schizophrenia	8.31e-05	0.000304	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CNR1—schizophrenia	8.28e-05	0.000303	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CHRM1—schizophrenia	8.26e-05	0.000303	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	8.13e-05	0.000298	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD2—schizophrenia	8.11e-05	0.000297	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR7—schizophrenia	8.11e-05	0.000297	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	8.1e-05	0.000297	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	8.08e-05	0.000296	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD2—schizophrenia	8.07e-05	0.000296	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR7—schizophrenia	8.07e-05	0.000296	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL3RA—schizophrenia	8.05e-05	0.000295	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PNP—schizophrenia	7.97e-05	0.000292	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	7.94e-05	0.000291	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	7.94e-05	0.000291	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	7.87e-05	0.000288	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NRG3—schizophrenia	7.86e-05	0.000288	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TLE1—schizophrenia	7.86e-05	0.000288	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GFAP—schizophrenia	7.77e-05	0.000284	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TLE1—schizophrenia	7.69e-05	0.000281	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NRG3—schizophrenia	7.69e-05	0.000281	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM5—schizophrenia	7.68e-05	0.000281	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRL—schizophrenia	7.63e-05	0.000279	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GFAP—schizophrenia	7.6e-05	0.000278	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM5—schizophrenia	7.51e-05	0.000275	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TLE3—schizophrenia	7.44e-05	0.000272	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NDUFV2—schizophrenia	7.41e-05	0.000271	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TLE3—schizophrenia	7.28e-05	0.000266	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—S100B—schizophrenia	7.11e-05	0.00026	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCK—schizophrenia	7.02e-05	0.000257	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIP4K2A—schizophrenia	6.97e-05	0.000255	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCK—schizophrenia	6.87e-05	0.000252	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDE4B—schizophrenia	6.84e-05	0.000251	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ERBB4—schizophrenia	6.8e-05	0.000249	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCKAR—schizophrenia	6.73e-05	0.000247	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	6.7e-05	0.000245	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	6.59e-05	0.000241	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	6.53e-05	0.000239	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.47e-05	0.000237	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	6.42e-05	0.000235	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PLA2G4A—schizophrenia	6.39e-05	0.000234	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	6.39e-05	0.000234	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP26B1—schizophrenia	6.3e-05	0.000231	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	6.28e-05	0.00023	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NRG1—schizophrenia	6.27e-05	0.00023	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGA—schizophrenia	6.26e-05	0.000229	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	6.26e-05	0.000229	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MEF2C—schizophrenia	6.22e-05	0.000228	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGA—schizophrenia	6.12e-05	0.000224	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	6.12e-05	0.000224	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	6.1e-05	0.000223	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	6.1e-05	0.000223	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPY—schizophrenia	6.1e-05	0.000223	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—YWHAZ—schizophrenia	6.01e-05	0.00022	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	5.97e-05	0.000219	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPY—schizophrenia	5.97e-05	0.000219	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	5.97e-05	0.000219	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	5.95e-05	0.000218	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OXT—schizophrenia	5.89e-05	0.000216	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1B—schizophrenia	5.89e-05	0.000216	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ERBB3—schizophrenia	5.88e-05	0.000215	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	5.76e-05	0.000211	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OXT—schizophrenia	5.76e-05	0.000211	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	5.68e-05	0.000208	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1A—schizophrenia	5.67e-05	0.000207	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—schizophrenia	5.66e-05	0.000207	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCLM—schizophrenia	5.61e-05	0.000206	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TPH1—schizophrenia	5.61e-05	0.000206	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPS—schizophrenia	5.58e-05	0.000204	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	5.56e-05	0.000204	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	5.54e-05	0.000203	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD1—schizophrenia	5.47e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2C—schizophrenia	5.47e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPS—schizophrenia	5.46e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD1—schizophrenia	5.35e-05	0.000196	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	5.35e-05	0.000196	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTRK2—schizophrenia	5.32e-05	0.000195	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD3—schizophrenia	5.3e-05	0.000194	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PRKD1—schizophrenia	5.28e-05	0.000193	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOE—schizophrenia	5.26e-05	0.000193	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	5.21e-05	0.000191	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOA1—schizophrenia	5.2e-05	0.00019	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD3—schizophrenia	5.18e-05	0.00019	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD4—schizophrenia	5.14e-05	0.000188	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD4—schizophrenia	5.03e-05	0.000184	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ESR1—schizophrenia	5.02e-05	0.000184	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CNR1—schizophrenia	4.91e-05	0.00018	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	4.83e-05	0.000177	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CNR1—schizophrenia	4.81e-05	0.000176	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD2—schizophrenia	4.79e-05	0.000176	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR7—schizophrenia	4.79e-05	0.000176	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD2—schizophrenia	4.69e-05	0.000172	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR7—schizophrenia	4.69e-05	0.000172	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GSK3B—schizophrenia	4.55e-05	0.000167	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRL—schizophrenia	4.53e-05	0.000166	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRL—schizophrenia	4.43e-05	0.000162	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GAPDH—schizophrenia	4.41e-05	0.000161	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CLOCK—schizophrenia	4.37e-05	0.00016	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNB2—schizophrenia	4.26e-05	0.000156	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TPH2—schizophrenia	4.26e-05	0.000156	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	4.25e-05	0.000156	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—S100B—schizophrenia	4.22e-05	0.000154	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DPYD—schizophrenia	4.19e-05	0.000153	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—S100B—schizophrenia	4.13e-05	0.000151	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	4.09e-05	0.00015	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ERBB4—schizophrenia	4.03e-05	0.000148	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	3.95e-05	0.000145	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1C—schizophrenia	3.89e-05	0.000143	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIK3C2A—schizophrenia	3.79e-05	0.000139	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	3.79e-05	0.000139	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NRG1—schizophrenia	3.72e-05	0.000136	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	3.71e-05	0.000136	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MEF2C—schizophrenia	3.69e-05	0.000135	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NRG1—schizophrenia	3.64e-05	0.000133	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	3.61e-05	0.000132	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.59e-05	0.000132	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	3.57e-05	0.000131	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	3.49e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	3.49e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	3.41e-05	0.000125	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SNAP25—schizophrenia	3.4e-05	0.000125	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP2D6—schizophrenia	3.4e-05	0.000125	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—schizophrenia	3.38e-05	0.000124	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	3.36e-05	0.000123	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	3.28e-05	0.00012	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—schizophrenia	3.12e-05	0.000114	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOA1—schizophrenia	3.08e-05	0.000113	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP1A2—schizophrenia	3.08e-05	0.000113	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—schizophrenia	3.06e-05	0.000112	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—schizophrenia	3.05e-05	0.000112	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TH—schizophrenia	3.03e-05	0.000111	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOA1—schizophrenia	3.02e-05	0.000111	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EP300—schizophrenia	3e-05	0.00011	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ESR1—schizophrenia	2.98e-05	0.000109	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ESR1—schizophrenia	2.91e-05	0.000107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	2.7e-05	9.9e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	2.64e-05	9.68e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—COMT—schizophrenia	2.58e-05	9.44e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTP1—schizophrenia	2.57e-05	9.4e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MAOA—schizophrenia	2.56e-05	9.38e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTM1—schizophrenia	2.36e-05	8.64e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLA2G4A—schizophrenia	2.36e-05	8.64e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TP53—schizophrenia	2.14e-05	7.85e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—schizophrenia	2.08e-05	7.63e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	2e-05	7.34e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	1.96e-05	7.18e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—schizophrenia	1.94e-05	7.11e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA1—schizophrenia	1.92e-05	7.02e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	1.82e-05	6.66e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—schizophrenia	1.81e-05	6.63e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	1.78e-05	6.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EP300—schizophrenia	1.78e-05	6.51e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EP300—schizophrenia	1.74e-05	6.37e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TP53—schizophrenia	1.27e-05	4.66e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TP53—schizophrenia	1.24e-05	4.56e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—EP300—schizophrenia	1.11e-05	4.05e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—schizophrenia	1.07e-05	3.94e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—schizophrenia	1.05e-05	3.85e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—schizophrenia	6.68e-06	2.45e-05	CbGpPWpGaD
